Table of Contents
Healthcare Providers in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the healthcare providers market in Japan
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the healthcare providers market in Japan
Leading company profiles reveal details of key healthcare providers market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Japan healthcare providers market with five year forecasts
Essential resource for top-line data and analysis covering the Japan healthcare providers market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Reasons To Buy
What was the size of the Japan healthcare providers market by value in 2015?
What will be the size of the Japan healthcare providers market in 2020?
What factors are affecting the strength of competition in the Japan healthcare providers market?
How has the market performed over the last five years?
What are the main segments that make up Japan's healthcare providers market?
The healthcare providers sector is valued as total expenditure on healthcare in each country. This includes final consumption spending on healthcare goods and services.
The Japanese healthcare providers sector had total revenues of $419.1bn in 2015, representing a compound annual growth rate (CAGR) of 1.7% between 2011 and 2015.
The inpatient care segment was the sector's most lucrative in 2015, with total revenues of $134.6bn, equivalent to 32.1% of the sector's overall value.
Government spending is high: it accounts for nearly 84% of total healthcare expenditure. This is because of the National Health Insurance program, which every Japanese citizen is required to participate in.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...
PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 Summary Hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections ...
OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025 Summary Diabetic Foot Ulcer (DFU) and Diabetic Foot Infection (DFI) market is set to triple in value from $292.1 Million ...